Germline heterozygous SETD2 pathogenic variants were first described in association with a Sotos-like congenital overgrowth disorder associated with macrocephaly, intellectual disability, autism and obesity [known as Luscan-Lumish syndrome (MIM:616831)] (7,28–31). Here, SETD2 is linked to Macrocephaly.